TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

Genscript Biotech Plunges After Chairman Of Chinese Gene And Cell Therapy Firm Is Arrested On Suspected Smuggling Offence
Play
HEALTH

Best Biotech Stocks to Buy in 2021

  • By Bret Jensen
  • Jan 15, 2021 8:26 AM EST
PRESS RELEASES

Axsome Therapeutics And Veeva Systems Partner To Build Axsome's Digital-Centric Commercialization™ Platform

  • By Business Wire
  • Nov 4, 2020 7:03 AM EST
Activist Investor to Block Partnership of Immunomedics and Seattle Genetics
INVESTING

Immunomedics, Scientific Games: 5 Top Gainers for Monday

  • By Rob Lenihan
  • Sep 14, 2020 4:21 PM EDT
Neurotrope Spins a Failed Alzheimer's Drug Study
INVESTING

Axsome Therapeutics Drug Trial Shows Eased Agitation in Alzheimer's Patients

  • By Dan Weil
  • Apr 27, 2020 1:06 PM EDT
Biotech Firm Sarepta Surges 40% on Positive Test Results
MARKETS

Biotech Stocks Post Double-Digit Gains in Monday Surge

  • By Scott Van Voorhis
  • Jan 7, 2019 6:49 PM EST
Heat Biologics Takes Beating After Pricing $12 Million Stock Offering
INVESTING

Heat Biologics Takes Beating After Pricing $12 Million Stock Offering

  • By Rob Lenihan
  • Nov 21, 2018 3:21 PM EST
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.